InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 14.36
-0.08 (-0.55%)
At close: Dec 5, 2025
InnoCare Pharma Revenue
InnoCare Pharma had revenue of 383.89M CNY in the quarter ending September 30, 2025, with 38.09% growth. This brings the company's revenue in the last twelve months to 1.43B, up 58.75% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.
Revenue (ttm)
1.43B CNY
Revenue Growth
+58.75%
P/S Ratio
17.88
Revenue / Employee
1.31M CNY
Employees
1,089
Market Cap
27.88B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 38.69B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |